Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial.

Joseph MoryousefÉmilie Bortolussi-CourvalTiina PodymowTodd C LeeEmilie TrinhEmily G McDonald

Published in: Canadian journal of kidney health and disease (2022)

MedSafer facilitates deprescribing in hospitalized patients on hemodialysis. Larger-scale implementation of decision support software for deprescribing in dialysis and long-term follow-up are likely required to demonstrate an impact on ADEs.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
primary care
healthcare
quality improvement
clinical trial